Clinical Trials Arena January 13, 2026
In 2026, clinical trial teams must be prepared to navigate market uncertainty and identify high-impact areas for AI adoption to remain competitive. We spoke with Jennifer Duff, Executive Vice President and General Manager of Zelta, to understand her view on the key industry trends that will define the year ahead.
As the clinical trial industry faces key challenges such as shifts, rising costs, and staffing challenges, 2026 is poised to be a pivotal year for teams to find efficiencies through modernizing study processes.
Twelve months ago, we interviewed Jennifer Duff, Executive Vice President and General Manager of Zelta, to discuss what the industry could expect in the year ahead.
Many of her predications hit the mark, from investment headwinds, a...
Today's Sponsors
Today's Sponsor